A mouse melanoma model reported that CD8+ TILs, under conditions of limited glucose and hypoxia, showed reduced glycolysis but enhanced FAO and that further promoting FAO enhanced the ability of CD8+ TILs to attenuate tumor progression (42). This evidence concerns the gene CD8A and melanoma.